These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14019685)

  • 1. [Mud therapy in prostatic diseases].
    CERHA W
    Arch Phys Ther (Leipz); 1962; 14():389-90. PubMed ID: 14019685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrarectal administration of mud for the treatment of chronic prostatitis].
    Lerenz T; Otreba L; Stolarczyk J
    Pol Przegl Chir; 1969; 41(4):Suppl 4a:491+. PubMed ID: 5805019
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further studies on the relationship between benign prostatic hyperplasia and prostatitis].
    Xia T
    Zhonghua Nan Ke Xue; 2004 Feb; 10(2):83-5. PubMed ID: 15027176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
    Shaplygin LV; Sivakov AA
    Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the management of prostate diseases: prostatitis and benign prostatic hyperplasia. Introduction.
    Nickel JC; Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():1. PubMed ID: 18307677
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA)].
    Golubchikov VA; Sitnikov NV; Kochetov AG; Perekhodov SN; Sidorov OV; Roiuk RV; Nagoprniuk VN; Tsibizov DN
    Urologiia; 2005; (4):9-12. PubMed ID: 16158737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of natural therapeutic factors of Belokurikha health resort in rehabilitation of patients with chronic prostatitis].
    Neĭmark AI; Bondarev EN
    Urologiia; 2005; (5):53-6. PubMed ID: 16281842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in researches on the relationship between prostatic diseases and erectile dysfunction].
    Zhan JC; Wei AY
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):462-5. PubMed ID: 15999496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rectal mud therapy in inflammatory diseases of the male adnexa].
    SILLO-SEIDL G
    Z Urol; 1961 Nov; 54():661-2. PubMed ID: 13912857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
    Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2007; (2):80-2. PubMed ID: 17578203
    [No Abstract]   [Full Text] [Related]  

  • 14. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Defects in spermatogenesis and their correction in patients with chronic abacterial prostatitis].
    Neĭmark AI; Aliev RT; Nozdrachev NA; Kraĭnichenko SV; El'chaninova SA; Zolovkina AG; Popovtseva AV; Bespalova OV
    Urologiia; 2008; (1):44, 46-50. PubMed ID: 18649680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
    Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of platelet-derived growth factor with benign prostatic hyperplasia].
    Chu J; Zhong HX
    Zhonghua Nan Ke Xue; 2007 Oct; 13(10):932-5. PubMed ID: 17977330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical approach to the prostate: an update.
    Kutikov A; Guzzo TJ; Malkowicz SB
    Radiol Clin North Am; 2006 Sep; 44(5):649-63, vii. PubMed ID: 17030218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Using some new technologies in medical rehabilitation in chronic prostatitis].
    Korzhachkina NB; Li AA; Kotenko KV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2007; (6):34-42. PubMed ID: 18277406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.